AR230988A1 - Un procedimiento para la preparacion de 9-amino-1-hidroxioctahidrobenzo(c)quinolinas y compuestos intermedios utilizados en el mismo - Google Patents

Un procedimiento para la preparacion de 9-amino-1-hidroxioctahidrobenzo(c)quinolinas y compuestos intermedios utilizados en el mismo

Info

Publication number
AR230988A1
AR230988A1 AR286204A AR28620481A AR230988A1 AR 230988 A1 AR230988 A1 AR 230988A1 AR 286204 A AR286204 A AR 286204A AR 28620481 A AR28620481 A AR 28620481A AR 230988 A1 AR230988 A1 AR 230988A1
Authority
AR
Argentina
Prior art keywords
hydroxioctahidrobenzo
quinolins
amino
procedure
preparation
Prior art date
Application number
AR286204A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR230988A1 publication Critical patent/AR230988A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AR286204A 1980-07-28 1981-07-24 Un procedimiento para la preparacion de 9-amino-1-hidroxioctahidrobenzo(c)quinolinas y compuestos intermedios utilizados en el mismo AR230988A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/173,207 US4309545A (en) 1980-07-28 1980-07-28 Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof

Publications (1)

Publication Number Publication Date
AR230988A1 true AR230988A1 (es) 1984-08-31

Family

ID=22630983

Family Applications (1)

Application Number Title Priority Date Filing Date
AR286204A AR230988A1 (es) 1980-07-28 1981-07-24 Un procedimiento para la preparacion de 9-amino-1-hidroxioctahidrobenzo(c)quinolinas y compuestos intermedios utilizados en el mismo

Country Status (29)

Country Link
US (1) US4309545A (fr)
EP (1) EP0045171B1 (fr)
JP (1) JPS57112372A (fr)
KR (1) KR850000273B1 (fr)
AR (1) AR230988A1 (fr)
AT (1) ATE11775T1 (fr)
AU (1) AU525944B2 (fr)
CA (1) CA1178274A (fr)
CS (1) CS228515B2 (fr)
DD (1) DD202012A5 (fr)
DE (1) DE3168891D1 (fr)
DK (1) DK334581A (fr)
EG (1) EG15535A (fr)
ES (1) ES504323A0 (fr)
FI (1) FI812338L (fr)
GR (1) GR75283B (fr)
GT (1) GT198170557A (fr)
HU (1) HU185133B (fr)
IE (1) IE51426B1 (fr)
IL (1) IL63423A0 (fr)
IN (1) IN158867B (fr)
NO (2) NO812557L (fr)
NZ (1) NZ197856A (fr)
PH (1) PH17281A (fr)
PL (1) PL133928B1 (fr)
PT (1) PT73440B (fr)
SU (1) SU1217254A3 (fr)
YU (1) YU185181A (fr)
ZA (1) ZA815128B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920221A (en) * 1982-03-16 1990-04-24 Pfizer Inc. Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines
US4642373A (en) * 1982-03-16 1987-02-10 Pfizer Inc. Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4473704A (en) * 1982-03-16 1984-09-25 Pfizer Inc. Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists
SI0882021T1 (en) * 1996-01-31 2003-10-31 Altana Pharma Ag New phenanthridines
SI0889886T1 (en) * 1996-03-26 2003-02-28 Altana Pharma Ag Novel phenanthridines substituted in the 6 position
US6127378A (en) * 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
IL133825A (en) * 1997-07-25 2005-12-18 Altana Pharma Ag Substituted 6-phenylphenanthridines, medicaments containing same and use thereof in the production of medicaments
WO1999005112A1 (fr) * 1997-07-25 1999-02-04 Byk Gulden Lomberg Chemische Fabrik Gmbh 6-alkylphenanthridines substituees
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US6274635B1 (en) 1999-03-22 2001-08-14 Immugen Pharmaceuticals Inc. Alkylated resorcinol derivatives for the treatment of immune diseases
US20060084021A1 (en) * 2004-09-10 2006-04-20 Kubicek Chris A Wick holder
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
AU2003214226A1 (en) * 2002-03-18 2003-10-08 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
WO2005115375A1 (fr) * 2004-05-25 2005-12-08 Othera Pharmaceuticals, Inc. Medicaments et promedicaments oculoselectifs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839441A (en) * 1969-10-27 1974-10-01 Hoffmann La Roche Intermediates for partially hydrogenated phenanthridines
US3878219A (en) * 1973-07-13 1975-04-15 Abbott Lab 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
HU180917B (hu) 1976-05-17 1983-05-30 Pfizer Eljárás 5, 6, 6a, 7-tetrahidro-benzo [c] kinolin-9(8H)-on-származékok előállítására
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4152450A (en) * 1978-02-17 1979-05-01 Eli Lilly And Company 9-Amino-dibenzopyrans

Also Published As

Publication number Publication date
IE51426B1 (en) 1986-12-24
CA1178274A (fr) 1984-11-20
HU185133B (en) 1984-12-28
YU185181A (en) 1983-12-31
EP0045171A2 (fr) 1982-02-03
IL63423A0 (en) 1981-10-30
PT73440A (en) 1981-08-01
PL133928B1 (en) 1985-07-31
PL232331A1 (en) 1983-09-26
EG15535A (en) 1986-09-30
IE811686L (en) 1982-01-28
NZ197856A (en) 1984-10-19
EP0045171B1 (fr) 1985-02-13
ZA815128B (en) 1982-07-28
ATE11775T1 (de) 1985-02-15
IN158867B (fr) 1987-02-07
GR75283B (fr) 1984-07-13
NO812557L (no) 1982-01-29
FI812338L (fi) 1982-01-29
NO854454L (no) 1985-01-29
DD202012A5 (de) 1983-08-24
JPS57112372A (en) 1982-07-13
KR850000273B1 (ko) 1985-03-15
PT73440B (en) 1983-06-20
CS228515B2 (en) 1984-05-14
DK334581A (da) 1982-01-29
ES8301926A1 (es) 1982-12-16
GT198170557A (es) 1983-01-12
SU1217254A3 (ru) 1986-03-07
US4309545A (en) 1982-01-05
DE3168891D1 (en) 1985-03-28
ES504323A0 (es) 1982-12-16
PH17281A (en) 1984-07-06
KR830006217A (ko) 1983-09-20
AU7343481A (en) 1982-05-06
EP0045171A3 (en) 1982-04-28
AU525944B2 (en) 1982-12-09

Similar Documents

Publication Publication Date Title
ES499079A0 (es) Un procedimiento para la preparacion de un compuesto
ES554935A0 (es) Un procedimiento para la preparacion de pirazolo- y piridazo-pirazolinas, -piridazinas y -diacepinas
ES503528A0 (es) Un procedimiento para la preparacion de interferon
ES499077A0 (es) Un procedimiento para la preparacion de nuevos compuestos antihipercolesteremicos
ES501570A0 (es) Un procedimiento para la preparacion de microcapsulas de e- tilcelulosa
ES487358A0 (es) Un procedimiento para la preparacion de compuestos de cefem y cefam
ES506141A0 (es) Un procedimiento para la preparacion de piridin- y pira- cin-derivados
AR230988A1 (es) Un procedimiento para la preparacion de 9-amino-1-hidroxioctahidrobenzo(c)quinolinas y compuestos intermedios utilizados en el mismo
ES498922A0 (es) Un procedimiento para la preparacion de compuestos de polie-ter antibioticos
ES534218A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol
ES500897A0 (es) Un procedimiento para la preparacion de una mezcla de hidro-carburos
ES493506A0 (es) Un procedimiento para la preparacion de desacetil-cefalospo-rina c
ES502153A0 (es) Un procedimiento para la preparacion de compuestos n-acil-n- (cicloalquil) aminoacidos.
ES505019A0 (es) Un procedimiento para la preparacion de compuestos
IT8049274A0 (it) Procedimento per la preparazione dicomposti azobenzenici(caso 150-4345)
ES503565A0 (es) Un procedimiento para la preparacion de tilactona o un esterderivado de la misma
ES502120A0 (es) Procedimiento para la preparacion de compuestos de viniles- tilbeno
ES501232A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES502487A0 (es) Un procedimiento para la preparacion de guanidinas
ES505552A0 (es) Un procedimiento para la preparacion de 1h- o 2h-tetrazol-5-tiol
MX159006A (es) Un procedimiento para la obtencion de polimezclas terpolimericas mejoradas y composiciones de polimezclas por el mismo
ES500909A0 (es) Un procedimiento para la preparacion de tiazoles
ES499572A0 (es) Un procedimiento para la preparacion de nuevas guanilamidi- nas
ES505625A0 (es) Un procedimiento para la preparacion de nuevos derivados de 4-2-hidroxi-4(sustituido) fenil-naftalen-2-1h-onas y 2-oles.
ES501277A0 (es) Un procedimiento para la preparacion de perfluoroamidas